Emyria’s digital health platform – Openly – has won a major IT award.
Openly is registered as a Class II medical device and provides medical grade remote monitoring powered by a smartphone. Openly is part of Emyria’s Real-World Data capture platform and was built in close collaboration with our partners Happitech and WeGuide.
The ACS Digital Disrupter Awards celebrates the outstanding tech talent in the Australian industry and recognises the innovators, disruptors, leaders, emerging professionals, and tech superstars who are making a difference.
The Service Transformation for the Digital Consumer Award recognises a project that uses innovative ways to change how an organisation provides their services to the consumer. The project identifies process improvement, change implementation and management techniques used to deliver the outcome. The project provides a better digitally based experience to the customer with measurable controls and outputs.
Emyria’s Managing Director, Dr Michael Winlo, said: “At Emyria, our drug development and registration programs are guided by robust clinical data gathered with Real-World patients across our clinical network. The COVID pandemic motivated our development of Openly – an app which provides remote care, powered by a smartphone and backed by a clinical team. Openly was developed with our partners Happitech and WeGuide and is currently the only medical-grade Smartphone platform registered as a Class II medical device with the TGA.